Asarfi Hospital appoints Ashutosh Kumar Sinha & Co as cost auditor for FY27

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Asarfi Hospital appoints M/s Ashutosh Kumar Sinha & Co as cost auditor for FY27
  • Board approved the appointment on August 25, 2026, per Audit Committee recommendation
  • Filing made under Regulation 30 of SEBI LODR Regulations, 2015
  • Company cited inadvertent omission for delay in regulatory disclosure
powered bylight_fuzz_icon
50170257

*this image is generated using AI for illustrative purposes only.

Asarfi Hospital has appointed M/s Ashutosh Kumar Sinha & Co as its cost auditor for the financial year 2026-27. The company’s Board of Directors approved the appointment on August 25, 2026, following a recommendation from the Audit Committee.

The firm, based in Dhanbad with registration number 004660, will conduct the cost audit in compliance with Section 148 of the Companies Act, 2013 and Rule 13 of the Companies (Accounts) Rules, 2014.

Regulatory Disclosure

Asarfi Hospital Limited filed the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made on August 31, 2026.

The company noted that the filing was delayed due to an inadvertent omission in its regulatory filing process. It stated it is taking steps to strengthen internal compliance mechanisms to ensure timely disclosures in the future.

Auditor Details

M/s Ashutosh Kumar Sinha & Co is a firm of practicing cost accountants. The firm offers services including cost audit, certifications, setting up costing systems, cost consultancy, and costing-based turnaround strategies.

Particulars Details
Name of Cost Auditor M/s Ashutosh Kumar Sinha & Co
Firm Registration No. 004660
Location Dhanbad
Date of Appointment August 25, 2026
Term of Appointment Financial Year 2026-27

The disclosure confirmed there are no relationships between the directors and the appointed auditor.

Historical Stock Returns for Asarfi Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+1.07%-7.67%-6.70%+22.27%+65.69%0.0%

What specific internal compliance measures is Asarfi Hospital implementing to prevent future delays in SEBI regulatory filings?

How might the appointment of a Dhanbad-based cost auditor impact Asarfi Hospital's operational oversight and audit efficiency?

Could the delayed disclosure trigger any penalties or increased scrutiny from SEBI regarding Asarfi Hospital's corporate governance practices?

Asarfi Hospital board approves BSE Main Board migration and NSE listing

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Board approves migration from BSE SME to BSE Main Board and NSE listing
  • 21st AGM scheduled for September 18, 2026, with book closure from Sept 5-18
  • Directors' Report for FY26 approved, indicating compliance with listing criteria
  • Mr. Gopal Singh re-appointed as director; CS Sourav Mall named scrutinizer
  • M/s Ashutosh Kumar Sinha & Co. appointed as Cost Auditor for FY27
powered bylight_fuzz_icon
48620623

*this image is generated using AI for illustrative purposes only.

Asarfi Hospital Limited’s board of directors approved the company’s migration from the BSE SME Platform to the BSE Main Board and its proposed listing on the National Stock Exchange (NSE) on Tuesday, August 25, 2026.

The decision, subject to shareholder approval and necessary regulatory compliances, marks a significant step in the company’s strategy to broaden its investor base and enhance liquidity. The board also approved the Directors' Report for the financial year ended March 31, 2026, signaling that the company meets the stricter eligibility criteria required for main board listing.

Key Board Decisions

In addition to the listing proposal, the board finalized several key corporate governance matters during the meeting held at its registered office in Dhanbad, Jharkhand:

  • Director Re-appointment: The board approved the re-appointment of Mr. Gopal Singh (DIN: 01608342), who retires by rotation, as a director of the company.
  • AGM Date Fixed: The 21st Annual General Meeting (AGM) is scheduled for Friday, September 18, 2026, at 12:00 noon at Ritam Hall, Asarfi Hospital, Dhanbad.
  • Book Closure: The register of members will remain closed from September 5 to September 18, 2026. The cut-off date for e-voting eligibility is Friday, September 11, 2026.
  • Cost Auditor Appointment: M/s Ashutosh Kumar Sinha & Co., Cost Accountants (FRN: 004660), were appointed as the Cost Auditor for FY27.
  • Scrutinizer Appointment: CS Sourav Mall (Membership No. A67274) was appointed as the scrutinizer for the AGM voting process.
  • Authorised Signatory: Mr. Harendra Singh was nominated as the authorised signatory for executing bid and tender documents on behalf of the company.

What the Numbers Show

While the filing does not disclose specific financial metrics for FY26, the approval of the main board migration implies that Asarfi Hospital has met the net worth and profitability thresholds mandated by stock exchanges for such transitions. This strategic move, coupled with the approval of the annual report, suggests a stable financial position for the just-concluded fiscal year.

The company has engaged NSDL along with Cameo Corporate Services Limited to provide remote e-voting facilities to its members, ensuring transparent shareholder participation.

Historical Stock Returns for Asarfi Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+1.07%-7.67%-6.70%+22.27%+65.69%0.0%

How might the migration to the BSE Main Board and NSE listing impact Asarfi Hospital's stock liquidity and valuation compared to its previous SME platform performance?

What specific financial metrics or growth targets is the company likely to disclose in the upcoming FY27 annual report following its main board eligibility confirmation?

Could the re-appointment of Mr. Gopal Singh signal any strategic shifts in corporate governance or operational focus for the hospital chain?

More News on Asarfi Hospital

1 Year Returns:+65.69%